7月以来，医药板块显著调整，医药类ETF的收益率再度回撤。数据显示，今年以来超九成医药类ETF的收益率仍为负。然而，近期多只医药类ETF的份额出现回升，投资者越跌越买的操作再现。业内人士表示，目前公募基金医药股持仓比例和医药股的整体估值水平均处于低位，长期投资价值开始显现。

7月以来，医药板块显著调整，医药类ETF的收益率再度回撤。数据显示，今年以来超九成医药类ETF的收益率仍为负。然而，近期多只医药类ETF的份额出现回升，投资者越跌越买的操作再现。业内人士表示，目前公募基金医药股持仓比例和医药股的整体估值水平均处于低位，长期投资价值开始显现。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.